These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
511 related items for PubMed ID: 26412482
21. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD. JAMA; 1999 Jan 20; 281(3):261-7. PubMed ID: 9918482 [Abstract] [Full Text] [Related]
25. Antimicrobial-impregnated catheters for the prevention of catheter-related bloodstream infections. Lorente L. World J Crit Care Med; 2016 May 04; 5(2):137-42. PubMed ID: 27152256 [Abstract] [Full Text] [Related]
26. Cost/benefit analysis of chlorhexidine-silver sulfadiazine-impregnated venous catheters for femoral access. Lorente L, Lecuona M, Jiménez A, Lorenzo L, Diosdado S, Marca L, Mora ML. Am J Infect Control; 2014 Oct 04; 42(10):1130-2. PubMed ID: 25278411 [Abstract] [Full Text] [Related]
30. Impregnated central venous catheters for prevention of bloodstream infection in children (the CATCH trial): a randomised controlled trial. Gilbert RE, Mok Q, Dwan K, Harron K, Moitt T, Millar M, Ramnarayan P, Tibby SM, Hughes D, Gamble C, CATCH trial investigators. Lancet; 2016 Apr 23; 387(10029):1732-42. PubMed ID: 26946925 [Abstract] [Full Text] [Related]
31. Antimicrobial-impregnated central venous catheters for prevention of neonatal bloodstream infection (PREVAIL): an open-label, parallel-group, pragmatic, randomised controlled trial. Gilbert R, Brown M, Rainford N, Donohue C, Fraser C, Sinha A, Dorling J, Gray J, McGuire W, Gamble C, Oddie SJ, PREVAIL trial team. Lancet Child Adolesc Health; 2019 Jun 23; 3(6):381-390. PubMed ID: 31040096 [Abstract] [Full Text] [Related]
32. Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients. Carrasco MN, Bueno A, de las Cuevas C, Jimenez S, Salinas I, Sartorius A, Recio T, Generelo M, Ruiz-Ocaña F. Intensive Care Med; 2004 Apr 23; 30(4):633-8. PubMed ID: 14722639 [Abstract] [Full Text] [Related]
33. Five-Lumen Antibiotic-Impregnated Femoral Central Venous Catheters in Severely Burned Patients: An Investigation of Device Utility and Catheter-Related Bloodstream Infection Rates. Friedman BC, Mian MA, Mullins RF, Hassan Z, Shaver JR, Johnston KK. J Burn Care Res; 2015 Apr 23; 36(4):493-9. PubMed ID: 25407386 [Abstract] [Full Text] [Related]
34. Lower associated costs using rifampicin-miconazole‒impregnated catheters compared with standard catheters. Lorente L, Lecuona M, Ramos MJ, Jiménez A, Mora ML, Sierra A. Am J Infect Control; 2011 Dec 23; 39(10):895-7. PubMed ID: 21741122 [Abstract] [Full Text] [Related]
40. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Heard SO, Wagle M, Vijayakumar E, McLean S, Brueggemann A, Napolitano LM, Edwards LP, O'Connell FM, Puyana JC, Doern GV. Arch Intern Med; 1998 Jan 12; 158(1):81-7. PubMed ID: 9437382 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]